INTECH Investment Management’s XBiotech XBIT Stock Holding History

INTECH Investment Management’s Portfolio XBIT Stock Details XBIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-14,156	Closed	-$45.9K	–	2685
2025 Q1	$45.9K	Buy	+14,156	New	+$48.8K	﹤0.01%	2442

Other funds holding XBIT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

INTECH Investment Management's XBIT Position: Q2 2025 in Review

INTECH Investment Management sold out of XBiotech (XBIT) in Q2 2025, closing a stake of 14,156 shares — an estimated $45.9K sold.

INTECH Investment Management first reported a position in XBIT in Q1 2025 and held it in 1 quarter. The position peaked at $45.9K in Q1 2025. 53 funds tracked by Wall St. Rank hold XBIT as of Q2 2025.

INTECH Investment Management reported no remaining XBiotech position as of Q2 2025 after selling out during the quarter.
INTECH Investment Management sold 14,156 XBiotech shares in Q2 2025, an estimated $45.9K.
INTECH Investment Management first reported a position in XBiotech in Q1 2025 and held it in 1 quarter.
INTECH Investment Management's XBiotech position peaked at $45.9K in Q1 2025.
53 funds tracked by Wall St. Rank held XBiotech as of Q2 2025.

Based on INTECH Investment Management's 13F filing for Q2 2025, filed 8 Aug 2025.